tiprankstipranks
Trending News
More News >
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
US Market

Voyager Therapeutics (VYGR) Income Statement

Compare
1,317 Followers

Voyager Therapeutics Income Statement

Last quarter (Q3 2025), Voyager Therapeutics's total revenue was $13.37M, a decrease of -45.73% from the same quarter last year. In Q3, Voyager Therapeutics's net income was $-27.89M. See Voyager Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 80.00M$ 250.01M$ 40.91M$ 37.41M$ 171.13M
Gross Profit
$ 80.00M$ 157.84M$ -14.86M$ -36.37M$ 62.38M
Operating Expenses
$ 163.29M$ 35.82M$ 35.98M$ 37.25M$ 34.99M
Depreciation and Amortization
$ 4.73M$ 4.44M$ 6.19M$ 5.17M$ 3.82M
EBITDA
$ -78.56M$ 126.45M$ -39.65M$ -68.45M$ 31.20M
Operating Income
$ -83.29M$ 122.01M$ -50.84M$ -73.62M$ 27.38M
Other Income/Expenses
$ 18.95M$ 11.72M$ 4.45M$ 2.42M$ 9.36M
Pretax Income
$ -64.34M$ 133.74M$ -46.39M$ -71.20M$ 36.74M
Net Income
$ -65.00M$ 132.33M$ -46.41M$ -71.20M$ 36.74M
Per Share Metrics
Basic EPS
$ -1.13$ 3.08$ -1.21$ -1.75$ 0.99
Diluted EPS
$ -1.13$ 2.97$ -1.21$ -1.75$ 0.98
Weighted Average Shares Outstanding
57.67M 43.02M 38.36M 37.67M 37.13M
Weighted Average Shares Outstanding (Diluted)
57.67M 44.57M 38.36M 37.67M 37.35M
Currency in USD

Voyager Therapeutics Earnings and Revenue History